A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2022-08-22
AEs
4
Serious
0
Dropout signal
–
Adverse events
moderate
assessed
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-17 (study day 40); relationship: Y
moderate
assessed
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-11-27 (study day 81); relationship: not assessed
mild
assessed
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-01-12 (study day 127); relationship: not assessed
mild
assessed
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-02-24 (study day 170); relationship: not assessed
Data queries
No data queries.